T1	Participants 230 289	patients with refractory monosymptomatic nocturnal enuresis
T2	Participants 334 396	28 patients with refractory monosymptomatic nocturnal enuresis
T3	Participants 416 423	Group 1
T4	Participants 505 512	group 2
T5	Participants 761 826	2 groups were comparable in baseline clinical and urodynamic data
T6	Participants 837 856	13 patients (46.4%)
T7	Participants 887 895	14 (50%)
T8	Participants 944 971	11 group 1 patients (78.6%)
T9	Participants 1050 1070	2 (14.3%) in group 2
T10	Participants 1149 1156	group 1
T11	Participants 1263 1270	group 1
T12	Participants 1368 1375	group 2
T13	Participants 1455 1462	group 1
T14	Participants 1532 1539	group 2
T15	Participants 1629 1688	patients with refractory monosymptomatic nocturnal enuresis
T16	Participants 1699 1731	deterioration in some responders
